Suppr超能文献

波兰冠心病患者糖皮质激素受体基因中的遗传变异与颈动脉狭窄分析

Analysis of Genetic Variants in the Glucocorticoid Receptor Gene and Stenosis of the Carotid Artery in a Polish Population with Coronary Artery Disease.

作者信息

Gorący Jarosław, Gorący Anna, Wójcik-Grzeszczuk Aldona, Gorący Iwona, Rosik Jakub

机构信息

Independent Laboratory of Invasive Cardiology, Pomeranian Medical University, 70-111 Szczecin, Poland.

Department of Clinical and Molecular Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland.

出版信息

Biomedicines. 2022 Aug 7;10(8):1912. doi: 10.3390/biomedicines10081912.

Abstract

Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Early diagnosis and elimination of risk factors are crucial for better managing CVDs. Atherosclerosis, whose development might be associated with glucocorticoids (GCs), is a critical factor in the development of carotid artery (CA) stenosis and most other CVDs. To investigate the association of Tth111I, N363S, and ER22/23EK- polymorphisms and the incidence of CA stenosis. The study group consisted of 117 patients diagnosed with coronary artery disease (CAD) and CA stenosis and 88 patients with CAD and ruled out CA stenosis. Genomic DNA was extracted from blood, and genotyping was carried out using Tth111I, N363S, and ER22/23EK- polymorphism sequencing. No significant association between studied polymorphisms and the incidence or the severity of CA stenosis in the Polish population with CAD was found. This is the first study that proves that common gene variants do not influence CA stenosis and probably are not associated with atherosclerosis. The search for genes that can act as prognostic markers in predicting CA stenosis is still ongoing.

摘要

心血管疾病(CVDs)是全球首要死因。早期诊断和消除风险因素对于更好地管理心血管疾病至关重要。动脉粥样硬化是颈动脉(CA)狭窄及大多数其他心血管疾病发展的关键因素,其发展可能与糖皮质激素(GCs)有关。为了研究Tth111I、N363S和ER22/23EK-多态性与CA狭窄发生率之间的关联。研究组由117例被诊断为冠状动脉疾病(CAD)和CA狭窄的患者以及88例患有CAD但排除CA狭窄的患者组成。从血液中提取基因组DNA,并使用Tth111I、N363S和ER22/23EK-多态性测序进行基因分型。在患有CAD的波兰人群中,未发现所研究的多态性与CA狭窄的发生率或严重程度之间存在显著关联。这是第一项证明常见基因变异不会影响CA狭窄且可能与动脉粥样硬化无关的研究。寻找可作为预测CA狭窄预后标志物的基因的工作仍在进行中。

相似文献

引用本文的文献

1
Catestatin in Cardiovascular Diseases.心血管疾病中的降钙素抑制肽
Int J Mol Sci. 2025 Mar 7;26(6):2417. doi: 10.3390/ijms26062417.

本文引用的文献

1
Glucocorticoid Signaling and the Aging Heart.糖皮质激素信号与衰老心脏
Front Endocrinol (Lausanne). 2020 May 27;11:347. doi: 10.3389/fendo.2020.00347. eCollection 2020.
7
Potential targets of gene therapy in the treatment of heart failure.心力衰竭基因治疗的潜在靶点。
Expert Opin Ther Targets. 2018 Sep;22(9):811-816. doi: 10.1080/14728222.2018.1514012.
8
Pathophysiology of Glucocorticoid Signaling.糖皮质激素信号转导的病理生理学。
Ann Endocrinol (Paris). 2018 Jun;79(3):98-106. doi: 10.1016/j.ando.2018.03.001. Epub 2018 Apr 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验